Microbubbles for thrombolysis of acute ischemic stroke

Area of Science:

• Biomedical Engineering
• Neurology
• Pharmacology

Background:

• Acute ischemic stroke treatment often involves thrombolytic drugs.
• Ultrasound and microbubbles offer a promising adjunctive or alternative therapy for clot lysis.
• Optimal parameters and safety profiles for ultrasound-enhanced thrombolysis require further definition.

Purpose of the Study:

• To review the current state and future directions of ultrasound and microbubble-enhanced thrombolysis for acute ischemic stroke.
• To identify key areas of uncertainty regarding technique, dosage, and safety.
• To explore novel approaches like immunobubbles for targeted clot dissolution.

Main Methods:

• Review of recent findings in sonothrombolysis for ischemic stroke.
• Discussion of critical parameters including microbubble dosage, ultrasound settings, and thrombolytic drug combinations.
• Exploration of immunobubble technology for enhanced thrombus targeting.

Main Results:

• Ultrasound and microbubbles demonstrate potential for clot lysis in ischemic stroke, possibly without additional thrombolytic drugs.
• Targeting thrombi with immunobubbles may increase sonothrombolysis efficacy.
• Significant uncertainties remain regarding optimal protocols and safety.

Conclusions:

• Ultrasound-enhanced thrombolysis is a promising avenue for acute ischemic stroke treatment.
• Further research, including extensive animal studies, is essential to establish optimal techniques, indications, and safety for human translation.
• Novel strategies like immunobubbles warrant further investigation for improved efficacy.